The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #11 is a biotech by the name of Vistagen Therapeutics (VTGN). The reason why I want to go over this ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...
The hydrogel preservation technology maintains cell viability for days at room temperature, removing cold-chain constraints.